Home » Newsletters » BioWorld Science

BioWorld Science

May 9, 2005

View Archived Issues

S-23521, a novel GLP-1 analogue, prevents progression of diet-induced diabetes in an animal model

Clinical evidence supports the use of oral paricalcitol in SHPT

NXY-059 in acute ischemic stroke: first results of the SAINT I study

Enrollment completed in dose dense Abraxane study in adjuvant breast cancer

Conforma's Series C financing to fund development of Hsp90 inhibitors

Sorafenib accepted into Pilot 1 Program

Noxxon Pharma demonstrates in vivo efficacy of Spiegelmers in cancer

VioQuest to acquire Greenwich Therapeutics

Acorda reaches SPA agreement on Fampridine-SR phase III study in MS

Genentech IND cleared for phase I trial in basal cell carcinoma

BioMarin licenses further 6R-BH4 rights from Daiichi Suntory

Orphan drug designation for arimoclomol for ALS

SB-509 enters new phase I trial for diabetic neuropathy

Novel IGF-IR inhibitor synthesized

Milestones in Rigel and Daiichi collaboration

Cytochroma secures financing

Novel analgesic agents imparted by Neurogen, Euroceltique and Merz

Strong anticancer activity of novel MetAP2 inhibitors

Full enrollment reached in phase III ACCLAIM chronic heart failure trial

TL-310: a possible clinical candidate for cancer / News in Context

Novel agents for arthritis and other inflammatory disorders

Encouraging results with twice-daily avanafil

Schering-Plough discloses new therapeutic agents for erectile dysfunction

GSK discloses novel agents for renal and cardiovascular disorders and cancer

Rostaporfin prevents visual loss in wet AMD patients with occult CNV lesions

Update on the efficacy of ezetimibe plus statin therapy in hypercholesterolemia

Ornidazole prevents postoperative Crohn's disease recurrence

Telmisartan safe, effective in chronic kidney disease patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...